Effects of omeprazole and amoxycillin on the human oral and gastrointestinal microflora in patients with Helicobacter pylori infection

Journal of Antimicrobial Chemotherapy

Volumn 38, Issue 6, 1996, Pages 927-939

  Stark, C A ^a   Adamsson, I ^a   Edlund, C ^a   Sjosted S ^a   Seensalu, R ^a   Wikstrom B ^a   Nord, C E ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; BETA LACTAMASE; OMEPRAZOLE;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COLONIZATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ENTEROBACTERIACEAE; FECES; FECES CULTURE; FEMALE; HELICOBACTER PYLORI; HUMAN; INFECTION; MALE; MICROFLORA; MINIMUM INHIBITORY CONCENTRATION; MOUTH; NONHUMAN; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; SALIVA; STOMACH ANTRUM; STOMACH BIOPSY; TOOTH PLAQUE;

EID: 0030473876     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/38.6.927     Document Type: Article

References (22)

1. Brismar, B., Edlund, C. & Nord, C. E. (1993). Impact of cefpodoxime proxetil and amoxicillin on the normal oral and intestinal microflora. European Journal of Clinical Microbiology and Infectious Diseases 12, 714-9.
2. Chachaty, E., Bourneix, C, Renard, S., Bonnay, M. & Andremont, A. (1993). Shedding of Clostridium difficile, fecal β-lactamase activity, and gastrointestinal symptoms in 51 volunteers treated with oral cefixime. Antimicrobial Agents and Chemotherapy 37, 1432-5.
3. Edlund, C., Stark, C. & Nord, C. E. (1994). The relationship between an increase in β-lactamase activity after oral administration of three new cephalosporins and protection against intestinal ecological disturbances. Journal of Antimicrobial Chemotherapy 34, 127-38.
4. Gad, A. (1988). Campylobacter pylori and gastroduodenal disease. Clinical and morphological correlations. In The Duodenum (Bertaccini, G., Cheli, R., Dobrilla, G. et al., Eds), pp. 119-130. Cortina International-Raven Press.
5. Gad, A. & Unge, P. (1994). Antibacterial therapy of Helicobacter pylori-associated peptic ulcer disease: a new strategy. Journal of Clinical Gastroenterology 19, 6-10.
6. Heimdahl, A. & Nord, C. E. (1979). Effect of phenoxymethylpenicillin and clindamycin on the oral, throat and faecal microflora of man. Scandinavian Journal of Infectious Diseases 11, 233-42.
7. Jackson, D. P., Lewis, F. A., Taylor, G. R., Boylston, A. W. & Quirke, P. (1990). Tissue extraction of DNA and RNA and analysis by the polymerase chain reaction. Journal of Clinical Pathology 43, 499-504.
8. Lacey, R. W., Lord, V. L., Howson, G. L., Luxton, D. E. A. & Trotter, I. S. (1983). Double-blind study to compare the selection of antibiotic resistance by amoxycillin or cephradine in the commensal flora. Lancet i, 529-34.
9. Levy, S. B., Marshall, B., Schluederberg, S., Rowse, D. & Davis, J. (1988). High frequency of antimicrobial resistance in human faecal flora. Antimicrobial Agents and Chemotherapy 32, 1801-6.
10. Maton, P. N. (1991). Omeprazole. New England Journal of Medicine 324, 965-75.
11. Nakao, M., Tada, M., Tsuchimori, K. & Uekata, M. (1995). Antibacterial properties of lansoprazole alone and in combination with antimicrobial agents against Helicobacter pylori. European Journal of Clinical Microbiology and Infectious Diseases 14, 391-9.
12. National Institute of Health. (1994). Consensus Conference. Helicobacter pylori in peptic ulcer disease. Journal of the American Medical Association 272, 65-9.
13. Nord, C. E. (1990). Studies on the ecological impact of antibiotics. European Journal of Clinical Microbiology and Infectious Diseases 9, 517-8.
14. Nord, C. E. & Edlund, C. (1991). Ecological effects of antimicrobial agents on the human intestinal microflora. Microbial Ecology in Health and Disease 4, 193-207.
15. Norrby, S. R. (1986). Ecological consequences of broad spectrum versus narrow spectrum antibacterial therapy. Scandinavian Journal of Infectious Diseases Suppl. 49, 189-95.
16. O'Callaghan, C. H., Morris, A., Kirby, S. M. & Shingler, A. H. (1972). Novel method for detection of β-lactamases by using a chromogenic cephalosporin substrate. Antimicrobial Agents and Chemotherapy 1, 283-8.
17. Shanahan, P. M. A., Thomson, C. J. & Amyes, S. G. B. (1994). β-Lactam resistance in aerobic faecal flora from general practice patients in the UK. European Journal of Clinical Microbiology and Infectious Diseases 13, 760-3.
18. Sjöstedt, S., Kager, L., Veress, B. & Nord, C. E. (1989). Campylobacter pylori in relation to other aerobic and anaerobic microorganisms in patients with gastric diseases. Microbial Ecology in Health and Disease 2, 107-14.
19. Sjöstedt, S., Mostafa, M. A. M., Veress, B., Nord, C. E. & Seensalu, R. (1994). Implications of acid suppression in Helicobacter pylori treatment. 24 h-pH-monitoring before and during treatment with omeprazole and amoxicillin. American Journal of Gastroenterology 89, 1388 (Abstract 413).
20. Stark, C., Edlund, C., Hedberg, M. & Nord, C. E. (1995). Induction of β-lactamase by cefoxitin in anaerobic intestinal microflora. European Journal of Clinical Microbiology and Infectious Diseases 14, 18-24.
21. Stark, C., Edlund, C., Sjöstedt, S., Kristensen, G. & Nord, C. E. (1993). Antimicrobial resistance in human oral and intestinal anaerobic microfloras. Antimicrobial Agents and Chemotherapy 37, 1665-9.
22. Walsh, J. H. & Peterson, W. L. (1995). The treatment of Helicobacter pylori infection in the management of peptic ulcer disease. New England Journal Medicine 333, 984-91.